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Purpose: Various gastro-intestinal complications have been reported after
atrial fibrillation (Afib) radiofrequency (RF) ablation. The purpose of this
study was to prospectively evaluate the incidence of esogastric injuries after
Afib RF ablation.
Methods: Between June 2007 and April 2009, all patients (pts) in whom
Afib/left atrial flutter RF ablation was performed, underwent a systematic
upper gastro-intestinal endoscopy 24 hours after the procedure. Endoscopic
findings were classified as likely related to the procedure, potentially related
or unrelated.
Results: 100 ablation procedures were performed in 77 pts using a 4
mm irrigated-tip RF catheter with temperature set to 45°C. Ablation con-
sisted in antral isolation of pulmonary veins (PVI) in 63 cases (63%; max-
imum power: 30W), associated with creation of roof and left isthmus lines
in 14 (14%;35W), and additional left atrial fragmented electrograms abla-
tion in 23 (23%;35W). Esogastric endoscopy found gastroparesia in 6
cases (6%), considered as likely related to the ablation and due to vagal
injury. Among these cases, 4 had left atrial fragmented electrograms abla-
tion (p<0.001). In 3 PVI cases (3%), localized esophagus erythema was
also considered as likely related to the ablation procedure. In 5 cases with
either Mallory Weiss-like syndrome (n=3) or circumferential esophagus
erythema (n=2), RF induced lesions could not be fully ruled out. In 3
cases, esophageal lesions were likely due to pre-operative trans-esophageal
echocardiography (2 hematomas and 1 proximal ulceration). In 45 cases
(45%), endoscopic abnormalities were considered as unrelated to the abla-
tion (gastritis, n=18; Barret’s esophagus, n=7; hiatal hernia, n=14). Endo-
scopy was normal in 43 cases (43%).
Conclusions: In this prospective study, the incidence of asymptomatic eso-
gastric injuries likely related to RF ablation was fairly high (9%). Gastro-
paresia was the main complication and was significantly associated with
extensive left atrial ablation.
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Long-term monitoring of 340 patients with a cardiac resynchroniza-
tion therapy: comparing CRT-P and CRT-D and evaluation of res-
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The main objective of this retrospective study is to analyze the future of
heart failure patients, refractory to optimal pharmacological treatment,
implanted by a system of bi-ventricular pacemaker (CRT-P) or defibrillator
(CRT-D).
Methods: 340 patients were implanted between the 1st January 1999 and
31 December 2007, aged 69 +/-10 years mainly men (80%). The total popula-
tion presented in part ischemic heart disease (56%), NYHA class III (79%)
and an indication of primary prevention (76%). The number of hospitalization
in the 6 months prior to implantation is an average of 1 +/-1. The population
was divided into 3 groups: 
Group 1: 49 patients implanted with a CRT-P before March 2003, 
Group 2: 84 patients implanted with a CRT-P after March 2003, 
Group 3: 207 patients implanted with a CRT-D after March 2003.
Results: For all 3 groups combined rate of responders was 75%, with a
reduction in particular, the NYHA class (p <0.001), number of hospitalizations
(p <0.001) and an increasing LVEF (p <0.001).
The curves of Kaplan-Meyer shows that there is a significant difference
between curves CRT-P and CRT-D curve, with a survival rate higher with the
CRT-D (Logrank:: Group1 vs. Group 3 p <0.01 and Group 2 vs Group 3
p<0.05).
Discussion: Treatment with bi-ventricular stimulation shows that 75% of
patients are improved compared to the criteria usually measured. It appears
that treatment with CRT-D provides a survival rate more important for a pop-
ulation significantly younger (66 +/-10 years).
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Background: Device related infections [DRI] are not well understood
in patients implanted with a cardiac resynchronization therapy [CRT]
device.
Objectives: The aim of this study was twofold: [1] to evaluate the prev-
alence of CRT DRI; [2] to analyze the predictive factors of CRT DRI.
Methods and Results: From January 2001 to May 2007, CRT implanta-
tion was obtained in 303 pts. The mean follow-up was 31±19 months. Pop-
ulation characteristics were: mean age of 70±10 years old; 56 female;
aetiology [202 dilated and 101 ischemic cardiomyopathy]; NYHA class
3.2±.3; LVEF [26±6%]; QRS [171±31] ms. Thirteen patients developed a
DRI: endocarditis in 4, pocket erosion in 3, pocket abscess in 5 and septi-
caemia in 1. The prevalence of DRI was 4.3%. By univariate analysis, pre-
dictive factors of DRI were: procedure time [skin to skin: median of 85 vs.
57.5 min; p=. 03], reintervention [54% vs. 6.5%; p <. 0001], hematoma
[31% vs. 8.6% p=. 01], lead dislodgment [23% vs. 6.2%; p=. 03], dialysis
[23.1% vs. 1.72%; p=. 003] and procedure type [CRT ICD [8.6%] vs. CRT
PM [1.6%] or up-grading procedure [1.5%]; p=. 03]. Four independent pre-
dictive factors of DRI were identified: procedure time [p=. 0002]; dialysis
[p=. 001]; reintervention [p=. 006] and procedure type [CRT ICD vs. other
procedures; p=. 01].
Conclusions: This study found that the prevalence of CRT DRI is close
to 4.3% at 2.6 years [1.7% per year incidence]. Four independent predic-
tive factors of infections were identified including reintervention, proce-
dure time, dialysis, and primo CRT-ICD implantation. These parameters
should be part of the risk-benefit evaluation in patients selected for CRT’s
implantation.
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Follow-up of Brugada syndrome patients without implantable cardio-
verter-defibrillator: the “Achilles’ heel” of current studies?
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Risk stratification for sudden cardiac death in asymptomatic Brugada syn-
drome (BS) patients is not perfect. Although follow-up of patients with an
implantable cardio-defibrillator (ICD) is reliable, follow-up for patients
without an ICD is less accurate.
Method: All patients seen at the Bordeaux CHU between 1999 and 2009
with BS (spontaneous type 1 or after flecainide or ajmaline test) were included
prospectively in the database, i.e. 187 patients (76 % men, 44 ±12 years).
Follow-up of non-implanted patients was carried out by consultation or annual
